574 related articles for article (PubMed ID: 31420505)
1. Solving the Global Continual Improvement and Innovation Challenge: How an Effective Pharmaceutical Quality System Can Transform Post-Approval Change Management.
Vinther A; Ramnarine E
PDA J Pharm Sci Technol; 2019; 73(5):517-521. PubMed ID: 31420505
[TBL] [Abstract][Full Text] [Related]
2. Industry One-Voice-of-Quality (1VQ) Solutions: Effective Management of Post-Approval Changes in the Pharmaceutical Quality System (PQS)-through Enhanced Science and Risk-Based Approaches.
Ramnarine E; Vinther A; Bruhin K; Tovar C; Colao M
PDA J Pharm Sci Technol; 2020; 74(4):456-467. PubMed ID: 32467177
[TBL] [Abstract][Full Text] [Related]
3. Industry One-Voice-of-Quality Solutions Management Review of Post-Approval Changes Guide.
Vinther A; Mohammed F; Ramnarine E
PDA J Pharm Sci Technol; 2021; 75(5):454-457. PubMed ID: 33723006
[TBL] [Abstract][Full Text] [Related]
4. Approaches to Design an Efficient, Predictable Global Post-approval Change Management System that Facilitates Continual Improvement and Drug Product Availability.
Vinther A; Ramnarine E; Gastineau T; O'Brien L; Brehm O; Fryrear D
Ther Innov Regul Sci; 2024 May; 58(3):433-442. PubMed ID: 38369639
[TBL] [Abstract][Full Text] [Related]
5.
Ramnarine E; O'Donnell K
PDA J Pharm Sci Technol; 2018; 72(3):338-345. PubMed ID: 29669814
[TBL] [Abstract][Full Text] [Related]
6. Managing Excipient Supplier Name and Address Changes in the Pharmaceutical Quality System.
Rolke R; Ramnarine E; Vinther A; Sawant A
PDA J Pharm Sci Technol; 2020; 74(2):286-288. PubMed ID: 32179712
[TBL] [Abstract][Full Text] [Related]
7. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
[TBL] [Abstract][Full Text] [Related]
8. Emerging technology: A key enabler for modernizing pharmaceutical manufacturing and advancing product quality.
O'Connor TF; Yu LX; Lee SL
Int J Pharm; 2016 Jul; 509(1-2):492-498. PubMed ID: 27260134
[TBL] [Abstract][Full Text] [Related]
9. Achieving continuous manufacturing for final dosage formation: challenges and how to meet them. May 20-21, 2014 Continuous Manufacturing Symposium.
Byrn S; Futran M; Thomas H; Jayjock E; Maron N; Meyer RF; Myerson AS; Thien MP; Trout BL
J Pharm Sci; 2015 Mar; 104(3):792-802. PubMed ID: 25501530
[TBL] [Abstract][Full Text] [Related]
10. A practical discussion of risk management for manufacturing of pharmaceutical products.
Mollah AH; Baseman HS; Long M; Rathore AS
PDA J Pharm Sci Technol; 2014; 68(3):271-80. PubMed ID: 25188348
[TBL] [Abstract][Full Text] [Related]
11. Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer.
Anyakora C; Ekwunife O; Alozie F; Esuga M; Ukwuru J; Onya S; Nwokike J
BMC Health Serv Res; 2017 Sep; 17(1):665. PubMed ID: 28923044
[TBL] [Abstract][Full Text] [Related]
12. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
[TBL] [Abstract][Full Text] [Related]
13. ICH Q10 Pharmaceutical Quality System Guidance: Understanding Its Impact on Pharmaceutical Quality.
VanDuyse SA; Fulford MJ; Bartlett MG
AAPS J; 2021 Nov; 23(6):117. PubMed ID: 34773177
[TBL] [Abstract][Full Text] [Related]
14. Specifications from a biotechnology industry perspective.
Garnick RL
Dev Biol Stand; 1997; 91():31-6. PubMed ID: 9413680
[TBL] [Abstract][Full Text] [Related]
15. Provable Data Integrity in the Pharmaceutical Industry Based on Version Control Systems and the Blockchain.
Steinwandter V; Herwig C
PDA J Pharm Sci Technol; 2019; 73(4):373-390. PubMed ID: 30770485
[TBL] [Abstract][Full Text] [Related]
16. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2016; (43):9-61. PubMed ID: 27491172
[TBL] [Abstract][Full Text] [Related]
17. A quality control method enhancement concept-Continual improvement of regulatory approved QC methods.
Åsberg D; Nilsson M; Olsson S; Samuelsson J; Svensson O; Klick S; Ennis J; Butterworth P; Watt D; Iliadou S; Karlsson A; Walker JT; Arnot K; Ealer N; Hernqvist K; Svensson K; Grinell A; Quist PO; Karlsson A; Fornstedt T
J Pharm Biomed Anal; 2016 Sep; 129():273-281. PubMed ID: 27442889
[TBL] [Abstract][Full Text] [Related]
18. Increasing Product Confidence-Shifting Paradigms.
Phillips M; Kashyap V; Cheung MS
PDA J Pharm Sci Technol; 2015; 69(6):736-42. PubMed ID: 26659104
[TBL] [Abstract][Full Text] [Related]
19. [Pharmaceutical product quality control and good manufacturing practices].
Hiyama Y
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2010; (128):1-16. PubMed ID: 21381389
[TBL] [Abstract][Full Text] [Related]
20. How development and manufacturing will need to be structured--heads of development/manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Nepveux K; Sherlock JP; Futran M; Thien M; Krumme M
J Pharm Sci; 2015 Mar; 104(3):850-64. PubMed ID: 25630721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
